Developing an Oral Presentation Assessment to the Teacher Education Program Student
International Educational Research · 2018
DOI: 10.30560/ier.v1n1p43 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Educational Research, 2018. Verfasst von Nuansa Bayu Segara und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Performance evaluation of an oral presentation in the lecture process should be valid and accountable to avoid subjectivity and bias on the assessment. Based on ADDIE models, the researcher makes an oral presentation instrument for peer assessment, developed, implemented and tested statistically. Teacher candidates participate directly in the evaluation process based on the oral presentation rubric. The rubric became a guide for students in determining the criteria and performance measurement scale oral presentation of his colleagues. Statistical tests performed with Second Order Confirmatory Factor Analysis (CFA) Order using the Smart PLS 3.0. This instrument was built based on three dimensions of oral presentation: content, delivery, and collaboration. As a result, all three of it were found to be statistically valid and reliable, meeting the criteria so that it can be used for peer assessment of oral presentation.
Zitieren
APA
Segara, N. B., Yana, E., & Febianti, Y. N. (2018). Developing an Oral Presentation Assessment to the Teacher Education Program Student. International Educational Research. https://doi.org/10.30560/ier.v1n1p43
Vancouver
Segara NB, Yana E, Febianti YN. Developing an Oral Presentation Assessment to the Teacher Education Program Student. International Educational Research. 2018. doi:10.30560/ier.v1n1p43
BibTeX
@article{Segara2018,
author = {Segara, Nuansa Bayu and Yana, Enceng and Febianti, Yopi Nisa},
title = {Developing an Oral Presentation Assessment to the Teacher Education Program Student},
journal = {International Educational Research},
year = {2018},
doi = {10.30560/ier.v1n1p43}
}
EUVIMED